CodeLab Capital Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Kristian Ikast

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	2.8yrs
Participación del CEO	0.05%
Permanencia media de la dirección	2.7yrs
Promedio de permanencia en la Junta Directiva	sin datos

Actualizaciones recientes de la dirección

Recent updates

CEO

Kristian Ikast

2.8yrs

Permanencia

Mr. Kristian Ikast is a Director of CodeLab Capital AS (formerly known as PatientSky Group AS) and serves as its Chief Executive Officer since August 27, 2021. Mr. Ikast is an Investor and served as Managi...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Kristian Ikast	CEO & Director	2.8yrs	sin datos	0.048% NOK 59.5k
Christoffer Mathiesen	Chief Financial Officer	2.5yrs	sin datos	sin datos
Kjell Solli	Managing Director of Norway	2.7yrs	sin datos	sin datos
Andreas Kruger	Co-founder & CTO of PaaS	no data	sin datos	sin datos
Sesame Baker	Chief People & Culture Officer	2yrs	sin datos	sin datos
Egil Noen	Chief Commercial Officer	3.3yrs	sin datos	sin datos

2.7yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de CODE se considera experimentado (2.6 años antigüedad media).

CodeLab Capital Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

No independent directors

No independent directors

PatientSky Group AS, Annual General Meeting, Jun 28, 2022

Chief Commercial Officer recently bought kr575k worth of stock

Co-founder & CTO recently sold kr1.1m worth of stock

PatientSky Group AS Announces Executive Appointments

Recent updates

New minor risk - Shareholder dilution

New minor risk - Financial data availability

New major risk - Share price stability

New major risk - Market cap size

CodeLab Capital AS to Report Q4, 2023 Results on Feb 23, 2024

First half 2023 earnings released

New major risk - Financial position

Jesper Melin Ganc-Petersen acquired an unknown minority stake in PatientSky Group AS.

Now 81% undervalued after recent price drop

Full year 2022 earnings released

PatientSky Group AS to Report Q1, 2023 Results on May 25, 2023

Third quarter 2022 earnings released

No independent directors

Third quarter 2022 earnings released

Second quarter 2022 earnings released

Now 23% undervalued after recent price drop

Price target decreased to kr5.00

No independent directors

PatientSky Group AS to Report First Half, 2022 Results on Aug 15, 2022

PatientSky Group AS, Annual General Meeting, Jun 28, 2022

Full year 2021 earnings: Revenues exceed analyst expectations

PatientSky Group AS to Report Q4, 2021 Results on Feb 22, 2022

Chief Commercial Officer recently bought kr575k worth of stock

Consensus EPS estimates fall to -kr0.30

PatientSky Group AS to Report First Half, 2021 Results on Sep 01, 2021

New 90-day low: kr11.81

Co-founder & CTO recently sold kr1.1m worth of stock

PatientSky Group AS Announces Executive Appointments

PatientSky Group AS (OB:PSKY-ME) completed the acquisition of Infodoc AS and Acino AS.

PatientSky Group AS (OB:PSKY-ME) entered into a conditional share purchase agreement to acquire Infodoc AS and Acino AS for an enterprise value of approx. NOK 280 million.

CEO

Permanencia

Equipo directivo

Permanencia media